NOROCARP 50 MG/ML SOLUTION FOR INJECTION FOR CATTLE
מדינה: אירלנד
שפה: אנגלית
מקור: HPRA (Health Products Regulatory Authority)
מאפייני מוצר
(SPC)
18-12-2014
מסמכים מסוימים עבור מוצר זה אינם זמינים כרגע, אתה יכול לשלוח בקשה לשירות הלקוחות שלנו ואנחנו נודיע לך ברגע שנוכל להשיג אותם.
שלח בקשה.
שלח בקשה.
מרכיב פעיל:
CARPROFEN
זמין מ:
Norbrook Laboratories Limited
קוד ATC:
QM01AE91
INN (שם בינלאומי):
CARPROFEN
כמות:
50 Mg/Ml
טופס פרצבטיות:
Solution for Injection
סוג מרשם:
POM
קבוצה תרפויטית:
Bovine
איזור תרפויטי:
Carprofen
סממני תרפויטית:
N.S.A.I.D
מצב אישור:
Authorised
תאריך אישור:
2005-09-09
מאפייני מוצר
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Norocarp 50 mg/ml Solution for Injection for Cattle.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Solution for Injection.
A clear colourless to pale yellow solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Reduction of pyrexia in acute cases of infectious respiratory disease in cattle, in combination with appropriate anti-infective
therapy.
4.3 CONTRAINDICATIONS
Do not use in animals suffering from cardiac, hepatic or renal impairment.
Do not use in animals suffering from gastro-intestinal ulceration or bleeding.
Do not use where there is evidence of a blood dyscrasia.
Do not use in animals with known hypersensitivity to the product.
Do not use in pregnant animals refer to section 4.7.
Active substance
Carprofen
50 mg/ml
Excipients
Ethanol (anhydrous)
100 mg/ml
Sodium Formaldehyde Sulphoxylate
2.0 mg/ml
For a full list of excipients, see section 6.1
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 03/12/2014_
_CRN 7019269_
_page number: 1_
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Do not exceed the stated dose or the duration of treatment.
Do not administer other NSAIDs concurrently or within 24 hours of each other. Some NSAIDs may be highly bound to
plasma proteins and compete with other highly bound drugs, which can lead to toxic effects.
Use in any animal less than 6 weeks of age, or in aged animals, may involve additional risk. If such use cannot be avoided
animals may require a reduced dosage and careful clinical management.
Avoid use
קרא את המסמך השלם
